The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. Our top tier team of star trial attorneys, acclaimed transactional lawyers and exceptionally talented partners and associates have earned a reputation for the relentless pursuit of perfection and a dauntless pursuit of success.
Proskauer advised Sixth Street on its entry into a senior secured credit facility of up to $500 million with Beam Therapeutics Inc. (Nasdaq: BEAM) for substantial, long-term...
United States
NEW YORK, February 26, 2026 –
Proskauer advised Sixth Street on its entry into a senior secured
credit facility of up to $500 million with Beam Therapeutics Inc.
(Nasdaq: BEAM) for substantial, long-term, non-dilutive capital to
fund the potential launch of ristoglogene autogetemcel (risto-cel)
in sickle cell disease.
The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. Our top tier team of star trial attorneys, acclaimed transactional lawyers and exceptionally talented partners and associates have earned a reputation for the relentless pursuit of perfection and a dauntless pursuit of success.
